Afya (AFYA) Investor Day 2025 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2025 summary
29 Dec, 2025Strategic vision and future plans
Focus on integrating medical education, technology, and clinical practice to support physicians throughout their careers and create a unique ecosystem for healthcare professionals.
Expansion of postgraduate education hubs and digital solutions, with over 25 hubs, 70+ programs, and 33 campuses across 14 states serving over 25,000 students.
Launch of innovative products such as Afya Play, AfyaAssist, Whitebook AI, and expansion of embedded financial services including Afya Pay, automated payments, pension plans, and E&O insurance.
Ongoing investment in corporate venture capital and the launch of Instituto Afya, a non-profit aligned with the UN 2030 agenda, to foster health tech innovation and address non-communicable diseases.
Emphasis on data-driven solutions, B2B partnerships, and brand strength to maintain market leadership and expand the ecosystem's reach.
Financial guidance and performance
Consistent delivery of results within or above guidance since IPO, with 2024 net revenue at BRL 3.3 billion and adjusted EBITDA at BRL 1.4 billion; 2025 guidance projects net revenue of BRL 3.7–3.8 billion and adjusted EBITDA of BRL 1.6–1.7 billion.
Strong operating and cash flow growth, with a cash conversion ratio consistently above 90%, supporting investments, acquisitions, dividends, and share repurchases.
Net debt/EBITDA ratio below 1x, improved to 0.97 in 1H25, with recent debenture issuance and early settlement of Softbank convertible to reduce cost of debt and extend duration.
Over R$4.5 billion invested in 22 acquisitions since IPO, focused on undergraduate, continuing education, and medical practice assets.
Sustained gross margin performance in both education and medical practice solutions segments.
Innovation and differentiation
Unique academic model with integrated curriculum, AI-driven academic memorial, and internationally accredited simulation centers for practical training.
Pioneering use of AI and digital tools in education and medical practice, including virtual patients, bedside decision support, automated medical records, and personalized learning journeys.
High brand awareness, growing from 20% in early 2023 to nearly 70% in 2025, driving student and physician engagement.
Demonstrated social impact: cities with Afya units saw a 12% increase in physician density and improved health outcomes; ecosystem solutions impact physician behavior and patient outcomes.
Strategic partnerships with pharmaceutical companies and data providers, enabling targeted campaigns, sample distribution, and data-driven insights.
Latest events from Afya
- Double-digit growth in revenue, profit, and cash flow, with strong 2026 outlook and capital discipline.AFYA
Q4 202513 Mar 2026 - Double-digit growth, margin gains, and raised 2024 guidance driven by organic and acquisition-led expansion.AFYA
Q2 20242 Feb 2026 - Growth in medical education and digital health is driven by innovation, cash flow, and sector leadership.AFYA
Investor Day 202418 Jan 2026 - Net revenue and EBITDA rose over 16% and 25% YoY, with strong cash flow and margin gains.AFYA
Q3 202414 Jan 2026 - Double-digit growth, margin expansion, and strong cash flow with disciplined capital management.AFYA
Q3 202526 Dec 2025 - Net income up 60.1%, margin at 44.1%, and 2025 guidance signals further growth.AFYA
Q4 202425 Dec 2025 - Record EBITDA margin, strong cash flow, and market leadership marked the robust 1Q25 results.AFYA
Q1 202526 Nov 2025 - Double-digit revenue and EBITDA growth, margin gains, and buyback plans amid tax changes.AFYA
Q2 202523 Nov 2025